Incidence and clinical significance of Bcl-2/IgH rearrangements in follicular lymphoma

Leukemia and Lymphoma

Volumn 44, Issue 1, 2003, Pages 71-76

  Montoto, Silvia ^a   López Guillermo, Armando ^a   Colomer, Dolors ^b   Esteve, Jordi ^a   Bosch, Francesc ^a   Ferrer, Ana ^a   Villamor, Neus ^b   Moreno, Carolina ^b   Campo, Elías ^b   Montserrat, Emili ^a  

^a Postgraduate School of Hematology   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Bcl 2; Follicular lymphoma; Prognosis

Indexed keywords

CYCLOPHOSPHAMIDE; DNA; DOXORUBICIN; IMMUNOGLOBULIN HEAVY CHAIN; PREDNISONE; PROTEIN BCL 2; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; BLOOD ANALYSIS; BONE MARROW BIOPSY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; FEMALE; FOLLICULAR LYMPHOMA; GENE CLUSTER; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; INCIDENCE; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TIME; TREATMENT FAILURE;

AGED; AGED, 80 AND OVER; CHROMOSOME BREAKAGE; DISEASE-FREE SURVIVAL; FEMALE; GENE ORDER; GENES, BCL-2; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; INCIDENCE; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROBABILITY; PROGNOSIS; REMISSION INDUCTION; TREATMENT FAILURE;

EID: 0037232407     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000050052     Document Type: Article

References (32)

1. The Non-Hodgkin's Lymphoma Classification Project (1997) "A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma", Blood 89, 3909-3918.
2. Weiss, L.M., Warnke, R.A., Sklar, J. and Cleary, M.L. (1987) "Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas", New England Journal of Medicine 317, 1185-1189.
3. Yunis, J.J., Frizzera, G., Oken, M.M., et al. (1987) "Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer", New England Journal of Medicine 316, 79-84.
4. Vaandrager, J.W., Schuuring, E., Raap, T., et al. (2000) "Interphase FISH detection of BCL-2 rearrangement in follicular lymphoma using breakpoint-flanking probes", Genes, Chromosomes and Cancer 27, 85-94.
5. Amakaya, R., Fukuhara, S., Ohno, H., et al. (1989) "Involvement of bcl-2 gene in Japanese follicular lymphoma", Blood 73, 787-791.
6. Takechi, M., Tanaka, K., Hashimoto, T., et al. (1991) "Cytogenetic, molecular biological and clinical study of B-cell lymphomas with 14;18 translocation in Japanese patients", Leukemia 5, 1069-1075.
7. Johnson, A., Brun, A., Dictor, M., et al. (1995) "Incidence and prognostic significance of t(14;18) translocation in follicle center cell lymphoma of low and high grade. A report from southern Sweden", Annals of Oncology 6, 789-794.
8. Pezella, F., Ralfkiaer, E., Gatter, K.C. and Mason, D.Y. (1990) "The (14;18) translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction", British Journal of Haematology 76, 58-64.
9. Miettinem, M. and Lasota, J. (1997) "Polymerase chain reaction based gene rearrangement studies in the diagnosis of follicular lymphoma-Performance in formaldehyde-fixed tissue and application in clinical problem cases", Pathology Research and Practice 193, 9-19.
10. Segal, G.H., Jorgensen, T., Scott, M. and Braylan, R.C. (1994) "Optimal primer selection for clonality assessment by polymerase chain reaction analysis: follicular lymphomas", Human Pathology 25, 1276-1282.
11. Horsman, D.E., Gascoyne, R.D., Coupland, R.W., et al. (1995) "Comparison of cytogenetic analysis, Southern analysis, and polymerase chain reaction for the detection of t(14;18) in follicular lymphoma", American Journal of Clinical Pathology 103, 472-478.
12. Seite, P., Hillion, J., D'Agay, M.F., et al. (1993) "Bcl-2 gene activation and protein expression in follicular lymphoma: a report on 64 cases", Leukemia 7, 410-417.
13. Lee, M.S., Blick, M.B., Pathak, S., et al. (1987) "The gene located at chromosome 18 band q21 is rearranged in uncultured diffuse lymphomas as well as follicular lymphomas", Blood 70, 90-95.
14. Hill, M.E., MacLennan, K.A., Cunningham, D.C., et al. (1996) "Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study", Blood 88, 1046-1051.
15. Hermine, O., Haioun, C., Lepage, E., et al. (1996) "Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma", Blood 87, 265-272.
16. Gascoyne, R.D., Adomat, S.A., Krajewski, S., et al. (1997) "Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma", Blood 90, 244-251.
17. Kramer, M.H.H., Hermans, J., Parker, J., et al. (1996) "Clinical significance of bcl-2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study", Journal of Clinical Oncology 14, 2131-2138.
18. Yunis, J.J., Mayer, M.G., Arnesen, M.A., Aeppli, D.P., et al. (1989) "Bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma", New England of Journal Medicine 320, 1047-1054.
19. López-Guillermo, A., Cabanillas, F., McDonnell, T.I., et al. (1999) "Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphomas", Blood 93, 3081-3087.
20. Pezella, F., Jones, M., Ralfkiaer, E., Ersboll, J., et al. (1992) "Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma", British Journal of Cancer 65, 87-89.
21. Harris, N.L., Jaffe, E.S., Stein, H., et al. (1994) "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group", Blood 84, 1361-1392.
22. Pinyol, M., Campo, E., Nadal, A., et al. (1996) "Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction", American Journal of Clinical Pathology 105, 532-537.
23. Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) "A simple salting out procedure for extracting DNA from human nucleated cells", Nucleic Acids Research 16, 1215.
24. Segal, G.H., Scott, M. and Braylan, R.C. (1996) "Semi-automated ELISA-based detection system for verifying the authenticity of amplified t(14;18)-containing products", Diagnostic Molecular Pathology 5, 114-120.
25. Gribben, J.G., Freedman, A.S., Woo, S.D., et al. (1991) "All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment", Blood 78, 3275-3280.
26. Ngan, B.Y., Nourse, J. and Cleary, M.L. (1989) "Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas", Blood 73, 1759-1762.
27. Kaplan, G.L. and Meier, P. (1958) "Nonparametric estimation from incomplete observations", Journal of the American Statistical Association 53, 457-481.
28. 2/E in the log-rank test for survival data on tumor incidence data", Biometrics 29, 759-784.
29. Colombat, P., Salles, G., Brousse, N., et al. (2001) "Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients follicular lymphoma with a low tumor burden: clinical and molecular evaluation", Blood 97, 101-106.
30. Crescenzi, M., Seto, M., Herzig, G.P., et al. (1988) "Thermoestable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease", Proceedings of the National Academy of Science USA 85, 4869-4873.
31. Levine, E.G., Arthur, D.C., Frizzera, G., et al. (1988) "Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma", Annals of Internal Medicine 108, 14-20.
32. Tilly, H., Rossi, A., Stamatoullas, A., et al. (1994) "Prognostic values of chromosomal abnormalities in follicular lymphoma", Blood 84, 1043-1049.